Peritoneal Carcinomatosis and Multi-Organ Metastases are Prognostic Factors in Colorectal Cancer: A Retrospective Analysis
DOI:
https://doi.org/10.6000/1927-7229.2016.05.01.1Keywords:
Colorectal cancer, prognostic factors, peritoneal carcinomatosis, first line chemotherapy, multi-organ metastases.Abstract
Background: Peritoneal carcinomatosis and multi-organ metastases might be prognostic factors in patients with advanced colorectal cancer and inoperable metastases at diagnosis.
Methods: A retrospective study was performed to examine the relationship between patient clinical characteristics and prognosis in patients with colorectal cancer and indication for first-line systemic chemotherapy.
Results: One hundred and twelve patients were accrued. According to univariate analysis, peritoneal carcinomatosis, lack of primary tumour resection and multi-organ metastases were associated with poor overall survival. According to multivariate analysis, patients with peritoneal carcinomatosis and patients with multi-organ metastases had a shorter overall survival (12 vs 27.0 months, p<0.001 and 14,6 vs 27 months, p=0.007, respectively).
Conclusions: Our results indicate that presence of peritoneal carcinomatosis and multi-organ metastases are independent predictors of poor outcome for patients with colorectal cancer undergoing first line treatment with standard chemotherapy.
References
Surveillance, Epidemiology and End Results (SEER) Program [homepage on the Internet]. Available from www.seer.cancer.gov. Stat Database: Incidence-SEER 17. Nov 2006 Sub (1973-2004).
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual (7th ed), Eds. New York, NY: Springer 2010; p. 143.
Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62(1): 10-29. http://dx.doi.org/10.3322/caac.20138
Bleiberg H. Role of chemotherapy for advanced colorrectal cancer. New oportunities. Semin Oncol 1996; 23(1 Suppl 3): 42-50.
De Gramont A, Vignoud J, Tournigand C, Louvet C, André T, Varette C, et al. Oxaliplatin with high-dose leucovorin and 5- fluorouracil 48-hours continuous infusion in preatreated metastatic colorrectal cancer. Eur J Cancer 1997; 33(2): 214-9. http://dx.doi.org/10.1016/S0959-8049(96)00370-X
Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280(6): C1358-66.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9(6): 669-76. http://dx.doi.org/10.1038/nm0603-669
Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001; 7(9): 987-9. http://dx.doi.org/10.1038/nm0901-987
Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005; 23(16): 3706-12. http://dx.doi.org/10.1200/JCO.2005.00.232
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23): 2335-42. http://dx.doi.org/10.1056/NEJMoa032691
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25(12): 1539-44. http://dx.doi.org/10.1200/JCO.2006.09.6305
Saltz L, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatinbased chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26(12): 2013-9. http://dx.doi.org/10.1200/JCO.2007.14.9930
Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Chen S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46(12): 1646-1652. http://dx.doi.org/10.1007/BF02660770
Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006; 202(3): 468-75. http://dx.doi.org/10.1016/j.jamcollsurg.2005.11.008
Leichman L. The role of chemotherapy in the curative treatment of patients with liver metastases from colorectal cancer. Surg Oncol Clin N Am 2007; 16: 537-556. http://dx.doi.org/10.1016/j.soc.2007.04.003
Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-1102. http://dx.doi.org/10.1016/S0016-5085(97)70119-7
Eker B, Ozaslan E, Karaca H, Berk V, Bozhurt O, Inanc M,
et al. Factors affecting prognosis in metastatic colorectal cancer patients. Asian Pac J Cancer Prev 2015; 16: 3015-21. http://dx.doi.org/10.7314/APJCP.2015.16.7.3015
Miyamoto Y, Hayashi N, Sakamoto Y, Ohuchi M, Tokunagam R, Kurashige J, et al. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single center retrspective analysis. Int J Clin Oncol 2015; published online.
Yun HR, Lee WY, Lee WS, Cho YB, Yun SH, Chun HK. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient’s status. Int J Colorectal Dis 2007; 22(11): 1301-1310. http://dx.doi.org/10.1007/s00384-007-0315-x
Mijamoto Y, Hayashi N, Sakamoto Y, Oushi M, Tokunagam R, Kurashige J. Predctors of long-term survival in patients with stage IV colorrectal cancer with multi-organ metastases: a single-center retrospective análisis. Int J Clin Oncol published online: 07 May 2015.
Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases—a systematic review. Eur J Cancer 2012; 48(12): 1757-1765. http://dx.doi.org/10.1016/j.ejca.2011.10.034
Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-367. http://dx.doi.org/10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V
Jimenez-Perez J, Caellas J, Garcia-Cano J, Vandervoort J, García Escribano OR, Barcenilla J, et al. Colonic Stenting as a bridge to surgery in malignant large-bowel obstruction: a report from two large multinational restries. Am J Gastroenterol 2011; 106: 2174-2180. http://dx.doi.org/10.1038/ajg.2011.360
Haslinger M. Francescutti V, Attwood K, McCart JA, Fakih M, Kane JM 3rd, et al. A contemporany análisis of morbidity and outcomes in cytoredution/hyperthermic intraperitoneal chemoperfusion. Cancer Medicine 2013; 2: 334-342.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and pallliative surgery in patietns with peritoneal carcinomatosis of colorrectal cancer. J Clin Oncol 2003; 21: 3737-3743. http://dx.doi.org/10.1200/JCO.2003.04.187
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Vu Hong Thang, Lambert Skoog, Nguyen Ba Duc, Ta Thanh Van, Edneia Tani , Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- A. Espiau Romera, L. Baquedano Mainar, M.J. Puente Luján, R. Laborda Gotor, L. Ruiz Campo, M.A. Ruiz Conde, Preoperative HE4 Tumor Marker and Prognostic Factors in Endometrial Cancer: Review Article , Journal of Analytical Oncology: Vol. 8 (2019)
- Simona Di Francesco, Raffaele L. Tenaglia, Metabolic Alterations, Vascular Disease and Advanced Prostate Cancer: New Players for Metastatic Advanced Prostate Cancer? , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Abigail Ruiz de Lobera, Aitziber Buqué, Alberto Muñoz, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Eddy I. Gutierrez, Mikel Arruti, Inés Marrodán, Guillermo López-Vivanco, Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Agnaldo L. Silva-Filho, Andrezza V. Belo, Elisa Lopes Lages, Rívia Mara Lamaita, Márcia Mendonça Carneiro, Sílvia P. Andrade, Distinct Pattern of Inflammatory Enzyme Activities in Human Ovarian Cancer and Benign Myoma , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Mai Ashraf Talaat, The Influence of Radiation Therapy on Dental Implantation in Head and Neck Cancer Patients , Journal of Analytical Oncology: Vol. 12 (2023)
- Pedro Salinas Hernández, Rafael Trujillo Vilchez, Antonio Arriví García-Ramos, Rosana Grande Ladron de Guevara, Angeles Rodríguez Jaraiz, Pedro Gallurt Moreira, Jose Maria Vieitez de Prado, Miguel Ruiz López de Tejada, Antonio Irigoyen Medina, Juan Manuel Campos Cervera, Juan Carlos Cámara Vicario, Uriel Bohn Sarmiento, Pedro López Tendero, Juan Domingo Alonso Lajara, Ana León Carbonero, Marisa García de Paredes, Juan de Alvaro Liaño, Asunción Juarez Marroquí, Luis López Gómez , Diego Soto de Prado Otero, Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Antonieta Salud, Vicente Alonso, Pilar Escudero, Miguel Burillo, Cristina Martín, Fernando Rivera, Alfonso Yubero, Carlos García-Girón, Alberto Muñoz, Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Shu Yuasa, Megumi Kabeya, Ryuichi Furuta, Satoshi Hib, Chiaki Koga, Seiji Nagao, and Kenji Ina, A Case of Sigmoid Colon Cancer in which Somatic Pain was Rapidly Alleviated after Panitumumab Administration Despite Tumor Progression , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Sindhu Nagaraj, Rajesh Javarappa, V. Chendil, B.R. Kiran Kumar, Iqbal Ahmed, Amrut S. Kadam, Changes in Pulmonary Function and Development of Clinical Radiation Pneumonitis in Breast Cancer Patients following Post Mastectomy Radiation Therapy , Journal of Analytical Oncology: Vol. 9 (2020)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Omar Youssef, Virinder Kaur Sarhadi, Lauri Lehtimäki, Milja Tikkanen, Arto Kokkola, Pauli Puolakkainen, Gemma Armengol, Sakari Knuutila, Mutations by Next Generation Sequencing in Stool DNA from Colorectal Carcinoma Patients - A Literature Review and our Experience with this Methodology , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)